These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20940208)

  • 1. First patient enters trial to test safety of stem cells in spinal injury.
    Mayor S
    BMJ; 2010 Oct; 341():c5724. PubMed ID: 20940208
    [No Abstract]   [Full Text] [Related]  

  • 2. Caution urged in trial of stem cells to treat spinal-cord injury.
    Barde Y
    Nature; 2009 Mar; 458(7234):29. PubMed ID: 19262651
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechnology. Celebration and concern over U.S. trial of embryonic stem cells.
    Couzin J
    Science; 2009 Jan; 323(5914):568. PubMed ID: 19179496
    [No Abstract]   [Full Text] [Related]  

  • 4. Geron gets green light for human trial of ES cell-derived product.
    Alper J
    Nat Biotechnol; 2009 Mar; 27(3):213-4. PubMed ID: 19270655
    [No Abstract]   [Full Text] [Related]  

  • 5. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury.
    Faulkner J; Keirstead HS
    Transpl Immunol; 2005 Dec; 15(2):131-42. PubMed ID: 16412957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte progenitor cells: a missed opportunity.
    Watson RA; Tsakok MT; Yeung TM
    J Neurotrauma; 2012 Nov; 29(16):2593-4. PubMed ID: 22845890
    [No Abstract]   [Full Text] [Related]  

  • 7. Stem cells ready for prime time.
    Wadman M
    Nature; 2009 Jan; 457(7229):516. PubMed ID: 19177087
    [No Abstract]   [Full Text] [Related]  

  • 8. Embryonic stem cells. Researchers mull impact of Geron's sudden exit from field.
    Kaiser J
    Science; 2011 Nov; 334(6059):1043. PubMed ID: 22116849
    [No Abstract]   [Full Text] [Related]  

  • 9. GRNOPC1: the world's first embryonic stem cell-derived therapy. Interview with Jane Lebkowski.
    Lebkowski J
    Regen Med; 2011 Nov; 6(6 Suppl):11-3. PubMed ID: 21999256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target populations for first-in-human embryonic stem cell research in spinal cord injury.
    Bretzner F; Gilbert F; Baylis F; Brownstone RM
    Cell Stem Cell; 2011 May; 8(5):468-75. PubMed ID: 21549321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury.
    Lukovic D; Stojkovic M; Moreno-Manzano V; Bhattacharya SS; Erceg S
    Stem Cells Dev; 2014 Jan; 23(1):1-4. PubMed ID: 23980630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertainty.
    Hess PG
    Account Res; 2009 Jul; 16(4):175-98. PubMed ID: 20183160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH-d and Fos reactivity in the rat spinal cord following experimental spinal cord injury and embryonic neural stem cell transplantation.
    Dagci T; Sengul G; Keser A; Onal A
    Life Sci; 2011 Apr; 88(17-18):746-52. PubMed ID: 21376061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Funding windfall rescues abandoned stem-cell trial.
    Hayden EC
    Nature; 2014 Jun; 510(7503):18. PubMed ID: 24899284
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury.
    Priest CA; Manley NC; Denham J; Wirth ED; Lebkowski JS
    Regen Med; 2015 Nov; 10(8):939-58. PubMed ID: 26345388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?
    Watson RA; Yeung TM
    BMC Neurol; 2011 Sep; 11():113. PubMed ID: 21943254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials for the treatment of spinal cord injury: not so simple.
    Mackay-Sim A; Féron F
    Methods Mol Biol; 2013; 1059():229-37. PubMed ID: 23934846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informed consent and phase 1 research in spinal cord injury.
    Stenson K; Chen D; Tansey K; Kerkhoff TR; Butt L; Gallegos AJ; Kirschner KL
    PM R; 2010 Jul; 2(7):664-70. PubMed ID: 20659722
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced regeneration in spinal cord injury by concomitant treatment with granulocyte colony-stimulating factor and neuronal stem cells.
    Pan HC; Cheng FC; Lai SZ; Yang DY; Wang YC; Lee MS
    J Clin Neurosci; 2008 Jun; 15(6):656-64. PubMed ID: 18406145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of oligodendrocyte precursors derived from human embryonic stem cells.
    Sharp J; Keirstead HS
    Curr Opin Biotechnol; 2007 Oct; 18(5):434-40. PubMed ID: 18023336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.